PRCT

Time-Sensitive: Allegations focus on Procept's assurances about the handpiece-to-procedure differential and explanations that attributed revenue volatility to transient saline shortages rather than alleged inventory overstocking. NEW YORK, July 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in PROCEPT BIOROBOTICS CORPORATION (NASDAQ: PRCT) of a pending securities class action involving handpiece procedure differential medical technology securities allegations.

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ:PRCT) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws. If you invested in Procept, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/procept-biorobotics-class-action-lawsuit.

NEW YORK and NEW ORLEANS, July 28, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti , LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NasdaqGM: PRCT), if they purchased the Company's shares between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”).

NEW YORK--(BUSINESS WIRE)---- $PRCT #BFA--PROCEPT BioRobotics Sued for Securities Fraud after Undisclosed Discount Program Leads to 18% Stock Drop – Investors Notified to Contact BFA Law.

LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PROCEPT BioRobotics Corporation, (“PROCEPT” or the "Company") (NASDAQ: PRCT) investors of a class action on behalf of investors that bought securities between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). PROCEPT investors have until September 22, 2026 to file a lead plaintiff motion.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). PROCEPT investors have until September 22, 2026 to file a lead plaintiff motion.IF Y.

NEW YORK, July 27, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

NEW YORK--(BUSINESS WIRE)---- $PRCT #classactionlawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (“the Class Period”). If you suffered a loss on your Procept investments, you have until September 22, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications s.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NasdaqGM: PRCT), if they purchased the Company's shares between February 28, 2024 and February 25, 2026, inclusive (the “C.

SAN DIEGO, July 27, 2026 /PRNewswire/ -- Robbins LLP reminds investors that a securities class action has been filed on behalf of all purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). Investors who suffered significant losses during the Class Period may be eligible to participate in the lawsuit and should be aware of the upcoming September 22, 2026 deadline to seek appointment as lead plaintiff.